Synopsis: Thirumalai Chemicals Limited has secured overwhelming shareholder approval for a major cross-border financing structure that will allow its US subsidiary network to raise up to $140 million (nearly Rs. 1,170 crore). The near-unanimous 99.76% vote signals strong investor confidence as the company accelerates its global specialty chemicals expansion strategy, particularly in the high-value US market.
Thirumalai Chemicals Limited saw buying interest on Monday, rising 1.78% to Rs. 174.80 after hitting an intraday high of Rs. 179.61. The move came with healthy participation as the stock recorded 2.88 lakh shares traded with Rs. 5.09 crore turnover, while delivery volume remained strong at 59.10%, indicating steady investor accumulation despite the stock still being down 15.01% over the past month and 25.28% YTD.
Thirumalai Chemicals Limited has taken a major strategic step toward strengthening its international business operations after shareholders overwhelmingly approved a large overseas financing proposal that will allow its US-based subsidiary structure to raise up to $140 million in loan facilities. The results of the postal ballot, announced on June 12, 2026, showed exceptionally strong shareholder backing, with 99.76% of votes cast in favour of the resolution, making it one of the strongest shareholder mandates the company has secured for a major strategic initiative in recent years.
The voting process, conducted through the Central Depository Services Limited e-voting platform, saw participation from 239 shareholders, with a total of 59,049,740 valid votes cast. Of these, 58,910,806 votes supported the proposal, while only 138,934 votes opposed it, reflecting overwhelming investor confidence in management’s long-term global growth strategy. The resolution was independently scrutinised by R M Mimani & Associates LLP, confirming that the proposal passed comfortably under the provisions of the Companies Act, 2013.
At the core of the transaction is a sophisticated multi-layered financing structure involving multiple overseas subsidiaries within the Thirumalai Chemicals group. Under the approved structure, TCL Global BV, the company’s Netherlands-based subsidiary, will pledge its 100% equity stake in TCL Inc.. In turn, TCL Inc. will pledge its full ownership in TCL Specialties LLC, which will serve as the ultimate borrowing entity. Additionally, TCL Specialties LLC will create a first-charge security over its own assets, creating a layered collateral framework to support the proposed borrowing arrangement.
The financing scale is particularly notable when compared with the company’s current valuation. With Thirumalai Chemicals carrying an approximate market capitalisation of Rs. 2,100 – 2,200 crore, the proposed Rs. 1,170 crore financing facility represents nearly half of the company’s current market value, underlining the size and strategic importance of this overseas expansion initiative. Such a large financing arrangement suggests management is positioning aggressively to capture growth opportunities in the specialty chemicals segment, particularly within international markets where higher-margin specialty products often command significantly stronger pricing power.
This approval highlights a broader strategic shift in Thirumalai Chemicals Limited’ global business strategy. Instead of depending directly on the Indian parent company’s balance sheet, the company is using its international subsidiary network to raise long-term capital for overseas expansion. Through its global structure Thirumalai Chemicals, TCL Global BV, TCL Inc., TCL Specialties LLC the group can fund growth in international markets while reducing direct financial pressure on the listed Indian entity. The board has now been authorized to complete all agreements and regulatory processes required to execute the financing plan.
From a market perspective, this development has brought the stock into investor focus. Listed on the NSE as TIRUMALCHM and on the BSE under 500412, the company could attract stronger market attention as investors evaluate the long-term impact of this expansion-driven financing move. Large overseas capital deployment often reflects management confidence in future demand and business growth.
Company Overview
Founded in 1972 and headquartered in Mumbai, Thirumalai Chemicals Limited is a well-established specialty chemicals manufacturer with products used across industries such as plastics, paints, pharmaceuticals, food processing, and industrial manufacturing. The company has built a strong global presence over the years and operates with multiple international quality certifications, strengthening its position in the specialty chemicals sector.
For investors, the bigger takeaway goes beyond the financing approval itself. The overwhelming shareholder support, the large scale of the proposed borrowing, and the company’s aggressive overseas expansion strategy suggest that Thirumalai Chemicals is preparing for its next phase of global growth. If executed successfully, this move could strengthen its international business and potentially become an important long-term growth trigger for the stock.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
